Insights

Stay up to date on AI, pharma, financial services & more.

News, analysis and field notes from the SyncIQ team: what's moving in AI, and what it means for the documents your industry runs on.

Regulatory AIJune 2026

What a query-free dossier actually takes: lessons from five pilot programs

Where first drafts lose completeness, and which checks catch it before a health authority does.

SQSyncIQ Team8 min read

PlatformMay 2026

Source-linking is the feature regulated AI lives or dies on

Why claim-level traceability matters more than model choice for submission work.

SQSyncIQ Team6 min read

Regulatory intelligenceMay 2026

Reading the 2026 FDA guidance updates as a filing calendar

Turning this year's guideline changes into concrete submission-planning decisions.

SQSyncIQ Team5 min read

PlatformApril 2026

Blueprints, not prompts: keeping house style at scale

How configurable section blueprints turn guideline structure and prior submissions into a repeatable authoring standard.

SQSyncIQ Team7 min read

Regulatory AIApril 2026

The critique agent: what independent review means in practice

Severity-graded findings, four sources of truth, and why the reviewer can never be the author.

SQSyncIQ Team6 min read

ClinicalMarch 2026

CSR drafting from study data: where the time actually goes

A closer look at the slowest stretches of clinical authoring, and what a sourced first draft changes.

SQSyncIQ Team9 min read

Get Insights straight to your inbox.

New articles and analysis from the SyncIQ team, as they publish. No noise.

The flagship Agentic App

Regulatory Atlas.

The regulatory workspace that authors and reviews every submission: CMC dossiers, market expansions, variations, health authority responses, labels and regulatory intelligence, in one governed place.